Gormally John J 4/A
4/A · Akers Biosciences, Inc. · Filed Apr 10, 2018
Insider Transaction Report
Form 4/AAmended
Gormally John J
Chief Executive Officer
Transactions
- Award
Common Stock
2017-10-17$0.88/sh+150,000$132,000→ 180,000 total
Footnotes (1)
- [F1]On October 17, 2017, the Board of Directors of Akers Biosciences, Inc. approved the issuance of 150,000 restricted shares of common stock to the reporting person pursuant to the Akers Biosciences, Inc. 2017 Equity Incentive Plan.